カテゴリー： 世界, 医療/バイオ, LP Information

世界の血中循環がん細胞（CTC）検出器市場予測 2023年-2029年

【英語タイトル】Global Circulating Tumor Cell (CTC) Detector Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4351）・商品コード：LP23MY4351
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：97
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の血中循環がん細胞（CTC）検出器市場」は、過去の販売実績から2022年の世界の血中循環がん細胞（CTC）検出器の総販売量を検討し、2023年から2029年の予測される血中循環がん細胞（CTC）検出器の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の血中循環がん細胞（CTC）検出器の市場規模を掲載し、XXX百万米ドル規模の世界の血中循環がん細胞（CTC）検出器市場の詳細な分析を提供します。本インサイトレポートは、世界の血中循環がん細胞（CTC）検出器業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の血中循環がん細胞（CTC）検出器市場における各社の独自のポジションをより深く理解するために、血中循環がん細胞（CTC）検出器製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の血中循環がん細胞（CTC）検出器市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。血中循環がん細胞（CTC）検出器の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。血中循環がん細胞（CTC）検出器の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。血中循環がん細胞（CTC）検出器のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

血中循環がん細胞（CTC）検出器の世界主要メーカーとしては、Celsee、 YZYMED、 NanoLite Systems、 BGI、 Watson Biotechなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の血中循環がん細胞（CTC）検出器市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では血中循環がん細胞（CTC）検出器市場をセグメンテーションし、種類別 (輸入型CTC、国内製CTC)、用途別 (臨床用、科学研究用)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：輸入型CTC、国内製CTC

・用途別区分：臨床用、科学研究用

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の血中循環がん細胞（CTC）検出器市場の10年間の市場状況・展望は？
・世界および地域別に見た血中循環がん細胞（CTC）検出器市場成長の要因は何か？
・血中循環がん細胞（CTC）検出器の市場機会はエンドマーケットの規模によってどのように変化するのか？
・血中循環がん細胞（CTC）検出器のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：血中循環がん細胞（CTC）検出器の年間販売量2018-2029、地域別現状・将来分析
・血中循環がん細胞（CTC）検出器の種類別セグメント：輸入型CTC、国内製CTC
・血中循環がん細胞（CTC）検出器の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・血中循環がん細胞（CTC）検出器の用途別セグメント：臨床用、科学研究用
・血中循環がん細胞（CTC）検出器の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の血中循環がん細胞（CTC）検出器市場
・企業別のグローバル血中循環がん細胞（CTC）検出器市場データ：2018-2023年の年間販売量、市場シェア
・企業別の血中循環がん細胞（CTC）検出器の年間売上：2018-2023年の売上、市場シェア
・企業別の血中循環がん細胞（CTC）検出器販売価格
・主要企業の血中循環がん細胞（CTC）検出器生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

血中循環がん細胞（CTC）検出器の地域別レビュー
・地域別の血中循環がん細胞（CTC）検出器市場規模2018-2023：年間販売量、売上
・主要国別の血中循環がん細胞（CTC）検出器市場規模2018-2023：年間販売量、売上
・南北アメリカの血中循環がん細胞（CTC）検出器販売の成長
・アジア太平洋の血中循環がん細胞（CTC）検出器販売の成長
・ヨーロッパの血中循環がん細胞（CTC）検出器販売の成長
・中東・アフリカの血中循環がん細胞（CTC）検出器販売の成長

南北アメリカ市場
・南北アメリカの国別の血中循環がん細胞（CTC）検出器販売量、売上（2018-2023）
・南北アメリカの血中循環がん細胞（CTC）検出器の種類別販売量
・南北アメリカの血中循環がん細胞（CTC）検出器の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の血中循環がん細胞（CTC）検出器販売量、売上（2018-2023）
・アジア太平洋の血中循環がん細胞（CTC）検出器の種類別販売量
・アジア太平洋の血中循環がん細胞（CTC）検出器の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の血中循環がん細胞（CTC）検出器販売量、売上（2018-2023）
・ヨーロッパの血中循環がん細胞（CTC）検出器の種類別販売量
・ヨーロッパの血中循環がん細胞（CTC）検出器の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の血中循環がん細胞（CTC）検出器販売量、売上（2018-2023）
・中東・アフリカの血中循環がん細胞（CTC）検出器の種類別販売量
・中東・アフリカの血中循環がん細胞（CTC）検出器の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・血中循環がん細胞（CTC）検出器の製造コスト構造分析
・血中循環がん細胞（CTC）検出器の製造プロセス分析
・血中循環がん細胞（CTC）検出器の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・血中循環がん細胞（CTC）検出器の主要なグローバル販売業者
・血中循環がん細胞（CTC）検出器の主要なグローバル顧客

地域別の血中循環がん細胞（CTC）検出器市場予測レビュー
・地域別の血中循環がん細胞（CTC）検出器市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・血中循環がん細胞（CTC）検出器の種類別市場規模予測
・血中循環がん細胞（CTC）検出器の用途別市場規模予測

主要企業分析
Celsee、 YZYMED、 NanoLite Systems、 BGI、 Watson Biotech
・企業情報
・血中循環がん細胞（CTC）検出器製品
・血中循環がん細胞（CTC）検出器販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Circulating tumor cells (CTC) is generally referred to as the of all kinds of tumor cells in peripheral blood, lesions due to spontaneous or diagnosis and operation from solid tumors (primary tumors and metastases), most of CTCS in peripheral blood after apoptosis or be swallowed up, a few can escape and anchor the develop metastases, increase the risk of malignant tumor patients died.CTC circulating tumor cell detection equipment for the detection of isolated CTC circulating tumor cells.As new products continue to enter the market, the market competition is more and more fierce, the current industry’s gross profit rate is very high, but with the technical requirements and policy restrictions, the product price will tend to be stable, the gross profit rate will gradually decline.As the global economy recovers and health awareness increases, the demand for circulating tumor cell detection systems will continue to increase, especially in underdeveloped regions such as the brics countries with large populations and fast economic growth.The demand will continue to rise. Secondly, Europe and the United States will export production capacity to developing countries. In the future, the production capacity of Asia will continue to increase.
LPI (LP Information)’ newest research report, the “Circulating Tumor Cell (CTC) Detector Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cell (CTC) Detector sales in 2022, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cell (CTC) Detector sales for 2023 through 2029. With Circulating Tumor Cell (CTC) Detector sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cell (CTC) Detector industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cell (CTC) Detector landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circulating Tumor Cell (CTC) Detector portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cell (CTC) Detector market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cell (CTC) Detector and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cell (CTC) Detector.
The global Circulating Tumor Cell (CTC) Detector market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
In China, Circulating Tumor Cell (CTC) Detector key players include YZYMED, NanoLite Systems, etc. Global top two manufacturers hold a share over 65%.
East China is the largest market, with a share about 25%, followed by South Central China, and North China, both have a share over 40 percent.
In terms of product, Domestic CTC is the largest segment, with a share over 80%. And in terms of application, the largest application is Clinical Application, followed by Scientific Research.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cell (CTC) Detector market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Import CTC
Domestic CTC
Segmentation by application
Clinical Application
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Celsee
YZYMED
NanoLite Systems
BGI
Watson Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Circulating Tumor Cell (CTC) Detector market?
What factors are driving Circulating Tumor Cell (CTC) Detector market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Circulating Tumor Cell (CTC) Detector market opportunities vary by end market size?
How does Circulating Tumor Cell (CTC) Detector break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cell (CTC) Detector Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Circulating Tumor Cell (CTC) Detector by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Circulating Tumor Cell (CTC) Detector by Country/Region, 2018, 2022 & 2029
2.2 Circulating Tumor Cell (CTC) Detector Segment by Type
2.2.1 Import CTC
2.2.2 Domestic CTC
2.3 Circulating Tumor Cell (CTC) Detector Sales by Type
2.3.1 Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Type (2018-2023)
2.3.2 Global Circulating Tumor Cell (CTC) Detector Revenue and Market Share by Type (2018-2023)
2.3.3 Global Circulating Tumor Cell (CTC) Detector Sale Price by Type (2018-2023)
2.4 Circulating Tumor Cell (CTC) Detector Segment by Application
2.4.1 Clinical Application
2.4.2 Scientific Research
2.5 Circulating Tumor Cell (CTC) Detector Sales by Application
2.5.1 Global Circulating Tumor Cell (CTC) Detector Sale Market Share by Application (2018-2023)
2.5.2 Global Circulating Tumor Cell (CTC) Detector Revenue and Market Share by Application (2018-2023)
2.5.3 Global Circulating Tumor Cell (CTC) Detector Sale Price by Application (2018-2023)
3 Global Circulating Tumor Cell (CTC) Detector by Company
3.1 Global Circulating Tumor Cell (CTC) Detector Breakdown Data by Company
3.1.1 Global Circulating Tumor Cell (CTC) Detector Annual Sales by Company (2018-2023)
3.1.2 Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Company (2018-2023)
3.2 Global Circulating Tumor Cell (CTC) Detector Annual Revenue by Company (2018-2023)
3.2.1 Global Circulating Tumor Cell (CTC) Detector Revenue by Company (2018-2023)
3.2.2 Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Company (2018-2023)
3.3 Global Circulating Tumor Cell (CTC) Detector Sale Price by Company
3.4 Key Manufacturers Circulating Tumor Cell (CTC) Detector Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Circulating Tumor Cell (CTC) Detector Product Location Distribution
3.4.2 Players Circulating Tumor Cell (CTC) Detector Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Circulating Tumor Cell (CTC) Detector by Geographic Region
4.1 World Historic Circulating Tumor Cell (CTC) Detector Market Size by Geographic Region (2018-2023)
4.1.1 Global Circulating Tumor Cell (CTC) Detector Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Circulating Tumor Cell (CTC) Detector Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Circulating Tumor Cell (CTC) Detector Market Size by Country/Region (2018-2023)
4.2.1 Global Circulating Tumor Cell (CTC) Detector Annual Sales by Country/Region (2018-2023)
4.2.2 Global Circulating Tumor Cell (CTC) Detector Annual Revenue by Country/Region (2018-2023)
4.3 Americas Circulating Tumor Cell (CTC) Detector Sales Growth
4.4 APAC Circulating Tumor Cell (CTC) Detector Sales Growth
4.5 Europe Circulating Tumor Cell (CTC) Detector Sales Growth
4.6 Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales Growth
5 Americas
5.1 Americas Circulating Tumor Cell (CTC) Detector Sales by Country
5.1.1 Americas Circulating Tumor Cell (CTC) Detector Sales by Country (2018-2023)
5.1.2 Americas Circulating Tumor Cell (CTC) Detector Revenue by Country (2018-2023)
5.2 Americas Circulating Tumor Cell (CTC) Detector Sales by Type
5.3 Americas Circulating Tumor Cell (CTC) Detector Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cell (CTC) Detector Sales by Region
6.1.1 APAC Circulating Tumor Cell (CTC) Detector Sales by Region (2018-2023)
6.1.2 APAC Circulating Tumor Cell (CTC) Detector Revenue by Region (2018-2023)
6.2 APAC Circulating Tumor Cell (CTC) Detector Sales by Type
6.3 APAC Circulating Tumor Cell (CTC) Detector Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Circulating Tumor Cell (CTC) Detector by Country
7.1.1 Europe Circulating Tumor Cell (CTC) Detector Sales by Country (2018-2023)
7.1.2 Europe Circulating Tumor Cell (CTC) Detector Revenue by Country (2018-2023)
7.2 Europe Circulating Tumor Cell (CTC) Detector Sales by Type
7.3 Europe Circulating Tumor Cell (CTC) Detector Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cell (CTC) Detector by Country
8.1.1 Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales by Country (2018-2023)
8.1.2 Middle East & Africa Circulating Tumor Cell (CTC) Detector Revenue by Country (2018-2023)
8.2 Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales by Type
8.3 Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Circulating Tumor Cell (CTC) Detector
10.3 Manufacturing Process Analysis of Circulating Tumor Cell (CTC) Detector
10.4 Industry Chain Structure of Circulating Tumor Cell (CTC) Detector
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Circulating Tumor Cell (CTC) Detector Distributors
11.3 Circulating Tumor Cell (CTC) Detector Customer
12 World Forecast Review for Circulating Tumor Cell (CTC) Detector by Geographic Region
12.1 Global Circulating Tumor Cell (CTC) Detector Market Size Forecast by Region
12.1.1 Global Circulating Tumor Cell (CTC) Detector Forecast by Region (2024-2029)
12.1.2 Global Circulating Tumor Cell (CTC) Detector Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Circulating Tumor Cell (CTC) Detector Forecast by Type
12.7 Global Circulating Tumor Cell (CTC) Detector Forecast by Application
13 Key Players Analysis
13.1 Celsee
13.1.1 Celsee Company Information
13.1.2 Celsee Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
13.1.3 Celsee Circulating Tumor Cell (CTC) Detector Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Celsee Main Business Overview
13.1.5 Celsee Latest Developments
13.2 YZYMED
13.2.1 YZYMED Company Information
13.2.2 YZYMED Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
13.2.3 YZYMED Circulating Tumor Cell (CTC) Detector Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 YZYMED Main Business Overview
13.2.5 YZYMED Latest Developments
13.3 NanoLite Systems
13.3.1 NanoLite Systems Company Information
13.3.2 NanoLite Systems Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
13.3.3 NanoLite Systems Circulating Tumor Cell (CTC) Detector Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 NanoLite Systems Main Business Overview
13.3.5 NanoLite Systems Latest Developments
13.4 BGI
13.4.1 BGI Company Information
13.4.2 BGI Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
13.4.3 BGI Circulating Tumor Cell (CTC) Detector Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 BGI Main Business Overview
13.4.5 BGI Latest Developments
13.5 Watson Biotech
13.5.1 Watson Biotech Company Information
13.5.2 Watson Biotech Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
13.5.3 Watson Biotech Circulating Tumor Cell (CTC) Detector Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Watson Biotech Main Business Overview
13.5.5 Watson Biotech Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Circulating Tumor Cell (CTC) Detector Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Circulating Tumor Cell (CTC) Detector Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Import CTC
Table 4. Major Players of Domestic CTC
Table 5. Global Circulating Tumor Cell (CTC) Detector Sales by Type (2018-2023) & (Unit)
Table 6. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Type (2018-2023)
Table 7. Global Circulating Tumor Cell (CTC) Detector Revenue by Type (2018-2023) & ($ million)
Table 8. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Type (2018-2023)
Table 9. Global Circulating Tumor Cell (CTC) Detector Sale Price by Type (2018-2023) & (K USD/Unit)
Table 10. Global Circulating Tumor Cell (CTC) Detector Sales by Application (2018-2023) & (Unit)
Table 11. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Application (2018-2023)
Table 12. Global Circulating Tumor Cell (CTC) Detector Revenue by Application (2018-2023)
Table 13. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Application (2018-2023)
Table 14. Global Circulating Tumor Cell (CTC) Detector Sale Price by Application (2018-2023) & (K USD/Unit)
Table 15. Global Circulating Tumor Cell (CTC) Detector Sales by Company (2018-2023) & (Unit)
Table 16. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Company (2018-2023)
Table 17. Global Circulating Tumor Cell (CTC) Detector Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Company (2018-2023)
Table 19. Global Circulating Tumor Cell (CTC) Detector Sale Price by Company (2018-2023) & (K USD/Unit)
Table 20. Key Manufacturers Circulating Tumor Cell (CTC) Detector Producing Area Distribution and Sales Area
Table 21. Players Circulating Tumor Cell (CTC) Detector Products Offered
Table 22. Circulating Tumor Cell (CTC) Detector Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Circulating Tumor Cell (CTC) Detector Sales by Geographic Region (2018-2023) & (Unit)
Table 26. Global Circulating Tumor Cell (CTC) Detector Sales Market Share Geographic Region (2018-2023)
Table 27. Global Circulating Tumor Cell (CTC) Detector Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Circulating Tumor Cell (CTC) Detector Sales by Country/Region (2018-2023) & (Unit)
Table 30. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Country/Region (2018-2023)
Table 31. Global Circulating Tumor Cell (CTC) Detector Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Circulating Tumor Cell (CTC) Detector Sales by Country (2018-2023) & (Unit)
Table 34. Americas Circulating Tumor Cell (CTC) Detector Sales Market Share by Country (2018-2023)
Table 35. Americas Circulating Tumor Cell (CTC) Detector Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Circulating Tumor Cell (CTC) Detector Revenue Market Share by Country (2018-2023)
Table 37. Americas Circulating Tumor Cell (CTC) Detector Sales by Type (2018-2023) & (Unit)
Table 38. Americas Circulating Tumor Cell (CTC) Detector Sales by Application (2018-2023) & (Unit)
Table 39. APAC Circulating Tumor Cell (CTC) Detector Sales by Region (2018-2023) & (Unit)
Table 40. APAC Circulating Tumor Cell (CTC) Detector Sales Market Share by Region (2018-2023)
Table 41. APAC Circulating Tumor Cell (CTC) Detector Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Circulating Tumor Cell (CTC) Detector Revenue Market Share by Region (2018-2023)
Table 43. APAC Circulating Tumor Cell (CTC) Detector Sales by Type (2018-2023) & (Unit)
Table 44. APAC Circulating Tumor Cell (CTC) Detector Sales by Application (2018-2023) & (Unit)
Table 45. Europe Circulating Tumor Cell (CTC) Detector Sales by Country (2018-2023) & (Unit)
Table 46. Europe Circulating Tumor Cell (CTC) Detector Sales Market Share by Country (2018-2023)
Table 47. Europe Circulating Tumor Cell (CTC) Detector Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Circulating Tumor Cell (CTC) Detector Revenue Market Share by Country (2018-2023)
Table 49. Europe Circulating Tumor Cell (CTC) Detector Sales by Type (2018-2023) & (Unit)
Table 50. Europe Circulating Tumor Cell (CTC) Detector Sales by Application (2018-2023) & (Unit)
Table 51. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales by Country (2018-2023) & (Unit)
Table 52. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Circulating Tumor Cell (CTC) Detector Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Circulating Tumor Cell (CTC) Detector Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales by Type (2018-2023) & (Unit)
Table 56. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales by Application (2018-2023) & (Unit)
Table 57. Key Market Drivers & Growth Opportunities of Circulating Tumor Cell (CTC) Detector
Table 58. Key Market Challenges & Risks of Circulating Tumor Cell (CTC) Detector
Table 59. Key Industry Trends of Circulating Tumor Cell (CTC) Detector
Table 60. Circulating Tumor Cell (CTC) Detector Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Circulating Tumor Cell (CTC) Detector Distributors List
Table 63. Circulating Tumor Cell (CTC) Detector Customer List
Table 64. Global Circulating Tumor Cell (CTC) Detector Sales Forecast by Region (2024-2029) & (Unit)
Table 65. Global Circulating Tumor Cell (CTC) Detector Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Circulating Tumor Cell (CTC) Detector Sales Forecast by Country (2024-2029) & (Unit)
Table 67. Americas Circulating Tumor Cell (CTC) Detector Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Circulating Tumor Cell (CTC) Detector Sales Forecast by Region (2024-2029) & (Unit)
Table 69. APAC Circulating Tumor Cell (CTC) Detector Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Circulating Tumor Cell (CTC) Detector Sales Forecast by Country (2024-2029) & (Unit)
Table 71. Europe Circulating Tumor Cell (CTC) Detector Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales Forecast by Country (2024-2029) & (Unit)
Table 73. Middle East & Africa Circulating Tumor Cell (CTC) Detector Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Circulating Tumor Cell (CTC) Detector Sales Forecast by Type (2024-2029) & (Unit)
Table 75. Global Circulating Tumor Cell (CTC) Detector Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Circulating Tumor Cell (CTC) Detector Sales Forecast by Application (2024-2029) & (Unit)
Table 77. Global Circulating Tumor Cell (CTC) Detector Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Celsee Basic Information, Circulating Tumor Cell (CTC) Detector Manufacturing Base, Sales Area and Its Competitors
Table 79. Celsee Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
Table 80. Celsee Circulating Tumor Cell (CTC) Detector Sales (Unit), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2018-2023)
Table 81. Celsee Main Business
Table 82. Celsee Latest Developments
Table 83. YZYMED Basic Information, Circulating Tumor Cell (CTC) Detector Manufacturing Base, Sales Area and Its Competitors
Table 84. YZYMED Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
Table 85. YZYMED Circulating Tumor Cell (CTC) Detector Sales (Unit), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2018-2023)
Table 86. YZYMED Main Business
Table 87. YZYMED Latest Developments
Table 88. NanoLite Systems Basic Information, Circulating Tumor Cell (CTC) Detector Manufacturing Base, Sales Area and Its Competitors
Table 89. NanoLite Systems Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
Table 90. NanoLite Systems Circulating Tumor Cell (CTC) Detector Sales (Unit), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2018-2023)
Table 91. NanoLite Systems Main Business
Table 92. NanoLite Systems Latest Developments
Table 93. BGI Basic Information, Circulating Tumor Cell (CTC) Detector Manufacturing Base, Sales Area and Its Competitors
Table 94. BGI Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
Table 95. BGI Circulating Tumor Cell (CTC) Detector Sales (Unit), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2018-2023)
Table 96. BGI Main Business
Table 97. BGI Latest Developments
Table 98. Watson Biotech Basic Information, Circulating Tumor Cell (CTC) Detector Manufacturing Base, Sales Area and Its Competitors
Table 99. Watson Biotech Circulating Tumor Cell (CTC) Detector Product Portfolios and Specifications
Table 100. Watson Biotech Circulating Tumor Cell (CTC) Detector Sales (Unit), Revenue ($ Million), Price (K USD/Unit) and Gross Margin (2018-2023)
Table 101. Watson Biotech Main Business
Table 102. Watson Biotech Latest Developments
List of Figures
Figure 1. Picture of Circulating Tumor Cell (CTC) Detector
Figure 2. Circulating Tumor Cell (CTC) Detector Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Circulating Tumor Cell (CTC) Detector Sales Growth Rate 2018-2029 (Unit)
Figure 7. Global Circulating Tumor Cell (CTC) Detector Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Circulating Tumor Cell (CTC) Detector Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Import CTC
Figure 10. Product Picture of Domestic CTC
Figure 11. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Type in 2022
Figure 12. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Type (2018-2023)
Figure 13. Circulating Tumor Cell (CTC) Detector Consumed in Clinical Application
Figure 14. Global Circulating Tumor Cell (CTC) Detector Market: Clinical Application (2018-2023) & (Unit)
Figure 15. Circulating Tumor Cell (CTC) Detector Consumed in Scientific Research
Figure 16. Global Circulating Tumor Cell (CTC) Detector Market: Scientific Research (2018-2023) & (Unit)
Figure 17. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Application (2022)
Figure 18. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Application in 2022
Figure 19. Circulating Tumor Cell (CTC) Detector Sales Market by Company in 2022 (Unit)
Figure 20. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Company in 2022
Figure 21. Circulating Tumor Cell (CTC) Detector Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Company in 2022
Figure 23. Global Circulating Tumor Cell (CTC) Detector Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Circulating Tumor Cell (CTC) Detector Sales 2018-2023 (Unit)
Figure 26. Americas Circulating Tumor Cell (CTC) Detector Revenue 2018-2023 ($ Millions)
Figure 27. APAC Circulating Tumor Cell (CTC) Detector Sales 2018-2023 (Unit)
Figure 28. APAC Circulating Tumor Cell (CTC) Detector Revenue 2018-2023 ($ Millions)
Figure 29. Europe Circulating Tumor Cell (CTC) Detector Sales 2018-2023 (Unit)
Figure 30. Europe Circulating Tumor Cell (CTC) Detector Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales 2018-2023 (Unit)
Figure 32. Middle East & Africa Circulating Tumor Cell (CTC) Detector Revenue 2018-2023 ($ Millions)
Figure 33. Americas Circulating Tumor Cell (CTC) Detector Sales Market Share by Country in 2022
Figure 34. Americas Circulating Tumor Cell (CTC) Detector Revenue Market Share by Country in 2022
Figure 35. Americas Circulating Tumor Cell (CTC) Detector Sales Market Share by Type (2018-2023)
Figure 36. Americas Circulating Tumor Cell (CTC) Detector Sales Market Share by Application (2018-2023)
Figure 37. United States Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Circulating Tumor Cell (CTC) Detector Sales Market Share by Region in 2022
Figure 42. APAC Circulating Tumor Cell (CTC) Detector Revenue Market Share by Regions in 2022
Figure 43. APAC Circulating Tumor Cell (CTC) Detector Sales Market Share by Type (2018-2023)
Figure 44. APAC Circulating Tumor Cell (CTC) Detector Sales Market Share by Application (2018-2023)
Figure 45. China Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Circulating Tumor Cell (CTC) Detector Sales Market Share by Country in 2022
Figure 53. Europe Circulating Tumor Cell (CTC) Detector Revenue Market Share by Country in 2022
Figure 54. Europe Circulating Tumor Cell (CTC) Detector Sales Market Share by Type (2018-2023)
Figure 55. Europe Circulating Tumor Cell (CTC) Detector Sales Market Share by Application (2018-2023)
Figure 56. Germany Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Circulating Tumor Cell (CTC) Detector Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Circulating Tumor Cell (CTC) Detector Sales Market Share by Application (2018-2023)
Figure 65. Egypt Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Circulating Tumor Cell (CTC) Detector Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Circulating Tumor Cell (CTC) Detector in 2022
Figure 71. Manufacturing Process Analysis of Circulating Tumor Cell (CTC) Detector
Figure 72. Industry Chain Structure of Circulating Tumor Cell (CTC) Detector
Figure 73. Channels of Distribution
Figure 74. Global Circulating Tumor Cell (CTC) Detector Sales Market Forecast by Region (2024-2029)
Figure 75. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Circulating Tumor Cell (CTC) Detector Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Circulating Tumor Cell (CTC) Detector Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Circulating Tumor Cell (CTC) Detector Revenue Market Share Forecast by Application (2024-2029)

※参考情報

血中循環がん細胞（CTC）検出器は、がん診断の革新的なツールとして、血液中に循環しているがん細胞を検出するための装置または技術を指します。CTCは、主に原発性腫瘍から血流に入り込んだがん細胞であり、転移の過程において重要な役割を果たします。CTCの検出は、がんの早期発見や治療効果の評価、さらには転移のリスク評価において非常に有用です。

CTC検出器の定義としては、患者の血液サンプルを用いて循環するがん細胞を特定、分離、定量するために設計された機器または方法を含みます。このプロセスは、高度なセンサー技術や生物学的なマーカーを利用して行われます。 CTCSの存在は、腫瘍の特性や進行状況を示すバイオマーカーとしての役割も果たします。そのため、がんの診断や治療計画において重要な情報を提供します。

CTC検出器の主な特徴には、非侵襲性のサンプリング、迅速な結果取得、高い感度と特異性が挙げられます。通常、CTCを検出する方法は血液検査として行われるため、患者への負担が少なく、診断プロセスを迅速に行うことが可能です。また、CTCの数や特性を詳しく解析することで、個々の患者に応じた個別化医療の実施が期待されます。

CTC検出の方法は、いくつかの異なる技術が存在します。一般的には、フィルタリング、免疫捕捉、マイクロフルイディクス技術などが利用されています。フィルタリング技術は、血液中の細胞を物理的に分離する方法で、特定のサイズの細胞を選別し、その中からCTCを検出します。次に、免疫捕捉法では、特異的な抗体を用いてCTCを標識し、分離する技術です。この方法は、がん細胞特有のマーカーをターゲットにしているため、感度が高いとされています。

マイクロフルイディクス技術は、微細な流体を操作する技術を活用し、CTCを高精度に分離・分析できる利点があります。この技術は、標本の前処理を簡略化し、迅速かつ高感度な分析を可能にします。また、近年では人工知能（AI）や機械学習を取り入れたCTC検出器も登場しており、これによりデータ解析の精度や速度が向上しています。

CTC検出器の用途は多岐にわたります。主な用途には、がんの早期発見、療法の効果モニタリング、再発リスクの評価、個別化医療の支援などがあります。早期発見においては、CTCの数や特性を観察することで、疾患の進行度や治療の反応を判断する手助けになります。また、治療後のCTCの変化を追跡することで、患者の再発リスクを評価するための有用な情報を提供します。

さらに、CTC検査は新しい治療法の開発や臨床試験にも活用されており、がん治療の革新を促進しています。CTCの特性に基づいて、がん細胞の薬剤感受性や耐性についてのデータを収集することが可能となり、将来的にはより効果的ながん治療の選択ができるようになることが期待されます。

関連技術としては、液体バイオプシーや遺伝子解析技術が挙げられます。液体バイオプシーは、血液中の腫瘍由来DNA（ctDNA）やCTCなどのバイオマーカーを解析することで、がんの存在や進行状況を評価する方法です。これにより、CTCとの相互作用を理解し、相関関係を明らかにすることが可能となります。

CTC検出器は、今後のがん診断や治療において非常に重要な役割を果たすと期待されています。非侵襲的な特性や迅速な結果取得が可能であるため、多くの患者に負担をかけずに精度の高い情報を提供できるのです。また、技術の進歩とともに、CTCの特性をより深く理解するための研究も進んでおり、将来的にはより効果的ながん治療法の確立が実現できるでしょう。総じて、血中循環がん細胞検出器は、がん医療における革新技術であり、今後ますますその重要性が増すことが予想されます。


★調査レポート[世界の血中循環がん細胞（CTC）検出器市場予測 2023年-2029年] (コード：LP23MY4351)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血中循環がん細胞（CTC）検出器市場予測 2023年-2029年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆